Source:http://linkedlifedata.com/resource/pubmed/id/20833211
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-11-12
|
pubmed:abstractText |
Anticonvulsant properties of ?-asarone were studied in mice at three doses with different toxicity. The 100mg/kg dose decreased both treadmill performance and locomotor activity, caused hypothermia, and potentiated pentobarbital-induced sleep. The last two effects and no toxicity were observed at 60 and 22mg/kg, respectively. In chemical (pentylenetetrazole, picrotoxin, N-methyl-D-aspartate, pilocarpine) and electrical (maximal electroshock) seizure tests, neither seizures nor death were prevented by 60 mg/kg ?-asarone which, however, exhibited protective-like effects (delay in the onset of clonic and/or tonic seizures and/or in the death of mice). Magnesium deficiency-dependent audiogenic seizures responded to non-toxic doses of ?-asarone (60 mg/kg and less): 22 mg/kg protecting 50% of tested animals. Because these seizures respond to both anti-seizure and antioxidant compounds, antioxidant properties of ?-asarone were studied, indicating 5 Units of superoxide dismutase-like activity per mg ?-asarone. Treatment of mice by ?-asarone (daily dose of 100mg/kg during 7 days) induced brain antioxidant enzymes (superoxide dismutase, glutathione peroxidase and reductase) in striatum and hippocampus and to a lesser extent in cortex. In view of recent findings about deleterious roles of chronic inflammatory/oxidant stresses in human epilepsy outcome, antioxidant and inductive properties of ?-asarone are proposed to be coherent bases for traditional clinical efficacy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anisoles,
http://linkedlifedata.com/resource/pubmed/chemical/Anticonvulsants,
http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants,
http://linkedlifedata.com/resource/pubmed/chemical/Glutathione Peroxidase,
http://linkedlifedata.com/resource/pubmed/chemical/Glutathione Reductase,
http://linkedlifedata.com/resource/pubmed/chemical/Superoxide Dismutase,
http://linkedlifedata.com/resource/pubmed/chemical/asarone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1872-8111
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
337-44
|
pubmed:meshHeading |
pubmed-meshheading:20833211-Animals,
pubmed-meshheading:20833211-Anisoles,
pubmed-meshheading:20833211-Anticonvulsants,
pubmed-meshheading:20833211-Antioxidants,
pubmed-meshheading:20833211-Brain,
pubmed-meshheading:20833211-Disease Models, Animal,
pubmed-meshheading:20833211-Female,
pubmed-meshheading:20833211-Glutathione Peroxidase,
pubmed-meshheading:20833211-Glutathione Reductase,
pubmed-meshheading:20833211-Mice,
pubmed-meshheading:20833211-Motor Activity,
pubmed-meshheading:20833211-Seizures,
pubmed-meshheading:20833211-Superoxide Dismutase
|
pubmed:year |
2010
|
pubmed:articleTitle |
Activities of ?-asarone in various animal seizure models and in biochemical assays might be essentially accounted for by antioxidant properties.
|
pubmed:affiliation |
Toxicology Laboratory, Faculty of Pharmacy, Illkirch, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|